SCHEMBL7805902

SCHEMBL7805902

O=C1c2ccccc2C(=O)c2sc(-c3ccccc3F)nc21

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 7/20 0.63
TDO2 P48775 5/20 0.63
PTGS2 P35354 3/20 0.48
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
AHR P35869 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
DHODH Q02127 2/20 0.40
PTGS1 P23219 1/20 0.40
APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815304 0.88 IDO1 (0.55) IDO1TDO2PTGS2MAPTALDH1A1
SCHEMBL7805767 0.83 IDO1 (0.71) IDO1TDO2PTGS2MAPTALDH1A1
SCHEMBL7808047 0.81 IDO1 (0.79) IDO1TDO2PTGS2MEN1KMT2A
SCHEMBL7805716 0.79 IDO1 (0.62) IDO1TDO2PTGS2SMN1; SMN2DHODH
SCHEMBL6008193 0.79 PTGS2 (0.44) IDO1TDO2PTGS2ALDH1A1KDM4E
SCHEMBL7816954 0.78 IDO1 (1.00) IDO1TDO2PTGS2MAPTALDH1A1
SCHEMBL7974992 0.76 IDO1 (1.00) IDO1TDO2MAPTKMT2AALDH1A1
SCHEMBL7811800 0.76 IDO1 (0.62) IDO1TDO2PTGS2MAPTMEN1
SCHEMBL7816639 0.75 IDO1 (0.57) IDO1TDO2MAPTMEN1KMT2A
SCHEMBL7815259 0.75 IDO1 (0.63) IDO1TDO2ALDH1A1RAB9APTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed